‘What wound did ever heal but by degrees?’*
Restoring hemostatic thrombin generation at the time of cutaneous wounding does not normalize healing in hemophilia B
Redundant signaling of tissue factor and thrombin in cancer progression?
Transcriptional program induced by factor VIIa-tissue factor, PAR1 and PAR2 in MDA-MB-231 cells
How valid is it to conclude that long-term heparin use is not associated with osteoporosis?
Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density
Preventing pulmonary embolism and deep vein thrombosis
Thromboprophylaxis rates in US medical centers
Heritability of platelet function in families with premature coronary artery disease
Antiviral therapy for chronic hepatitis C in patients with inherited bleeding disorders
Vasodilator-stimulated phosphoprotein phosphorylation analysis prior to percutaneous coronary intervention for exclusion of postprocedural major adverse cardiovascular events
Inter-relationships of interleukin-6, cardiovascular risk factors and the metabolic syndrome among older men
Improved control of oral anticoagulant dosing
A pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study)
Pilot dose-finding and safety study of bivalirudin in infants <6 months of age with thrombosis
A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgery
Heparin-induced thrombocytopenia
Factor VII coagulant activity, factor VII −670A/C and −402G/A polymorphisms, and risk of venous thromboembolism
Platelet and coagulation activation markers in myeloproliferative diseases
Japanese collaborative study to assess inter-laboratory variation in factor VII activity assays
Role of cardiac myocyte tissue factor in heart hemostasis
The genetic interaction between VKORC1 c1173t and calumenin a29809g modulates the anticoagulant response of acenocoumarol
Changes in fibrinogen and fibrin induced by a peptide analog of fibrinogen γ365–380
Plasminogen gene expression is regulated by nerve growth factor
Plasminogen activator inhibitor-1 contributes to the deleterious effect of obesity on the outcome of thrombotic ischemic stroke in mice
Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in mice
Fibrinogen controls human platelet fibronectin internalization and cell-surface retention1
Genetic and pharmacologic evidence that Rac1 GTPase is involved in regulation of platelet secretion and aggregation
Mapping the platelet profile for functional genomic studies and demonstration of the effect size of the GP6 locus
Neuron-derived orphan receptor-1 (NOR-1) is induced by thrombin and mediates vascular endothelial cell growth
Apigenin-induced nitric oxide production involves calcium-activated potassium channels and is responsible for antiangiogenic effects
Platelet aggregation and adenosine triphosphate release values in children and adults
JAK2V617F is infrequently associated with arterial stroke in the absence of overt myeloproliferative disorder
Immobilization resulting from chronic medical diseases